Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России
Список исп. литературыСкрыть список Литература 1. Semple D, Smyth R. Oxford Handbook of Psychiatry (Fourth Edition). – Oxford: Oxford University Press, 2019; 1148 p. 2. Postpartum depression. MedlinePlus website. https://medlineplus.gov/ ency/article/007215.htm. Updated 2016. Accessed January 11, 2017. 3. Anderson PO. Antidepressants and breastfeeding. Breastfeed-Med, 2021; 16 (1): 5–7; doi: 10.1089/bfm.2020.0350. 4. Hutchens B.F., Kearney J. Risk factors for postpartum depression: An umbrella review. J-Midwifery-Womens-Health, 2020; 65 (1): 96–108; doi: 10.1111/jmwh.13067. 5. Shorey S., Chee C.Y.I., Ng E.D., Chan Y.H., Tam W.W.S., Chong Y.S. Prevalence and incidence of postpartum depression among healthy mothers: A systematic review and meta-analysis. J-Psychiatr-Res, 2018; 104: 235–48; doi: 10.1016/j.jpsychires.2018.08.001. 6. Beck CT. Postpartum depression. Stopping the thief that steals motherhood. Postpartum depression. Stopping the thief that steals motherhood. AWHONN-Lifelines, 1999; 3 (4): 41–4; doi: 10.1111/j.1552-6356.1999.tb01115.x. 7. Brockington I, Butterworth R, Glangeaud-Freudenthal N. An international position paper on mother-infant (perinatal) mental health, with guidelines for clinical practice. Arch-Womens-Ment-Health, 2017; 20 (1): 113-120; doi: 10.1007/s00737-016-0684-7. 8. Verbeek T, Bockting CLH. van Pampus MG, et al. Postpartum depression predicts offspring mental health problems in adolescence independently of parental lifetime psychopathology. J-Affect-Disord, 2012; 136 (3): 948-954; doi: 10.1016/j.jad.2011.08.035. 9. Johansen SL, Stenhaug B.A, Robakis TK, et al. Past psychiatric conditions as risk factors for postpartum depression: A nationwide cohort study. J-Clin-Psychiatry, 2020; 81 (1): 19m12929; doi: 10.4088/JCP.19m12929. 10. Lenze EJ, Mattar C, Zorumski CF, et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: A randomized clinical trial. JAMA, 2020; 324 (22): 2292-2300; doi: 10.1001/jama.2020.22760. 11. Anderson GM. Fluvoxamine, melatonin and COVID-19. Psychopharmacology (Berl), 2021; 238 (2): 611; doi: 10.1007/s00213-020-05753-z. 12. Leggett C, Costi L, Morrison JL, et al. Antidepressant use in late gestation and breastfeeding rates at discharge from hospital. J-Hum-Lact, 2017; 33 (4): 701–09. doi: 10.1177/0890334416678209. 13. Venkatesh KK, Castro VM, Perlis RH, et al. Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study. Study-J-Perinatol, 2017; 37 (9): 1003–9. doi: 10.1038/jp.2017.92. 14. Marshall AM, Nommsen-Rivers LA. Hernandez LL, et al. Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution. J-Clin-Endocrinol-Metab, 2010; 95 (2): 837-846; doi: 10.1210/jc.2009-1575. 15. Grzeskowiak LE, Leggett C, Costi L, et al. Impact of serotonin reuptake inhibitor use on breast milk supply in mothers of preterm infants: a retrospective cohort study. Br-J-Clin-Pharmacol, 2018; 84 (6): 1373-1379; doi: 10.1111/bcp.13575. 16. Uguz F, Kirkas A, Aksoy ZK, Yunden S. Use of psychotropic medication during lactation in postpartum psychiatric patients: Results from an 8-year clinical sample. Breastfeed-Med, 2020; 15 (8): 535-537; doi: 10.1089/bfm.2020.0111. 17. Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen R.E., Linde V.J., Knudsen H.E.D., Skaarup L., Videbech P, Danish Psychiatric Society; Danish Society of Obstetrics and Gynecology; Danish Paediatric Society; Danish Society of Clinical Pharmacology. Use of psychotropic drugs during pregnancy and breast-feeding. Review-Acta-Psychiatr-Scand-Suppl. 2015; (445): 1–28. doi: 10.1111/acps.12479. 18. Piontek CM, Wisner KL, Perel JM, et al. Serum fluvoxamine levels in breastfed infants. J-Clin-Psychiatry, 2001; 62 (2): 111-113; doi: 10.4088/jcp.v62n0207. 19. Frieder A, Fersh M, Hainline R, et al. Pharmacotherapy of postpartum depression: Current approaches and novel drug development. Review-CNS-Drugs, 2019; 33 (3): 265-282; doi: 10.1007/s40263-019-00605-7. 20. Amodeo G, Laurenzi PF, Santucci A, et al. Advances in treatment for postpartum major depressive disorder. Review-Expert-Opin-Pharmacother, 2020; 21 (14): 1685-1698; doi: 10.1080/14656566.2020.1779702.